Transforming growth factor beta2 is negatively regulated by endogenous retinoic acid during early heart morphogenesis.
Vitamin A-deficient (VAD) quail embryos lack the vitamin A-active form, retinoic acid (RA) and are characterized by a phenotype that includes a grossly abnormal cardiovascular system that can be rescued by RA. Here we report that the transforming growth factor, TGFbeta2 is involved in RA-regulated cardiovascular development. In VAD embryos TGFbeta2 mRNA and protein expression are greatly elevated. The expression of TGFbeta receptor II is also elevated in VAD embryos but is normalized by treatment with TGFbeta2-specific antisense oligonucleotides (AS). Administration of this AS or an antibody specific for TGFbeta2 to VAD embryos normalizes posterior heart development and vascularization, while the administration of exogenous active TGFbeta2 protein to normal quail embryos mimics the excessive TGFbeta2 status of VAD embryos and induces VAD cardiovascular phenotype. In VAD embryos pSmad2/3 and pErk1 are not activated, while pErk2 and pcRaf are elevated and pSmad1/5/8 is diminished. We conclude that in the early avian embryo TGFbeta2 has a major role in the retinoic acid-regulated posterior heart morphogenesis for which it does not use Smad2/3 pathways, but may use other signaling pathways. Importantly, we conclude that retinoic acid is a critical negative physiological regulator of the magnitude of TGFbeta2 signals during vertebrate heart formation.
Ghatpande
Satish K
SK
Department of Pediatrics, Yale University, New Haven, Connecticut, USA.
Zhou
Hui-Ren
HR
Cakstina
Inese
I
Carlson
Christopher
C
Rondini
Elizabeth A
EA
Romeih
Mahmoud
M
Zile
Maija H
MH
D000818:Animals; D018507:Gene Expression Regulation, Developmental; D006321:Heart / Q000196:embryology*; D009024:Morphogenesis / Q000187:drug effects; D011784:Quail / Q000196:embryology; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism; D053781:Transforming Growth Factor beta2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D014212:Tretinoin / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D014802:Vitamin A Deficiency / Q000378:metabolism
D018125:Receptors, Transforming Growth Factor beta; D053781:Transforming Growth Factor beta2; D014212:Tretinoin